Literature DB >> 26208820

Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function.

Wei Wang1, Jiye Li2, Runhua Pan2, Sileng A2, Caixian Liao3.   

Abstract

OBJECTIVES: The aim of this study was to investigate the association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function.
METHODS: Liver biopsy was performed for 30 patients with hepatitis B cirrhosis to test the content of hydroxyproline in hepatic tissue, judge the degree of cirrhosis and determine the Laennec staging system. The association of the Laennec staging system with the degree of cirrhosis, clinical stage and liver function was compared.
RESULTS: The Laennec staging system had a close association with clinical stage, model for end-stage liver disease score and degree of cirrhosis (r = 0.58, p < 0.01; r = 0.60, p < 0.01; r = 0.53, p < 0.01).
CONCLUSIONS: The Laennec histological grading system can to some extent reflect the degree of cirrhosis, clinical stage and liver function, and is expected to predict the incidence of patient complications in a useful way.

Entities:  

Keywords:  Cirrhosis; Clinical stage; Collagen; Pathological grading

Mesh:

Substances:

Year:  2015        PMID: 26208820     DOI: 10.1007/s12072-015-9648-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  18 in total

1.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2005-07       Impact factor: 25.083

2.  Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.

Authors:  Satish Nagula; Dhanpat Jain; Roberto J Groszmann; Guadalupe Garcia-Tsao
Journal:  J Hepatol       Date:  2005-09-23       Impact factor: 25.083

3.  Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.

Authors:  I R Wanless; E Nakashima; M Sherman
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

Review 4.  Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Scott Friedman; John Iredale; Massimo Pinzani
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

5.  Transient elastography: a new noninvasive diagnostic tool for assessment of chronic allograft nephropathy.

Authors:  V Lukenda; I Mikolasevic; S Racki; I Jelic; D Stimac; L Orlic
Journal:  Int Urol Nephrol       Date:  2014-03-29       Impact factor: 2.370

6.  Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.

Authors:  Soon Koo Baik; Dong Hun Park; Moon Young Kim; Yeun Jong Choi; Hyun Soo Kim; Dong Ki Lee; Sang Ok Kwon; Young Ju Kim; Joong Wha Park; Sei Jin Chang
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

7.  A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Authors:  C L Lai; R N Chien; N W Leung; T T Chang; R Guan; D I Tai; K Y Ng; P C Wu; J C Dent; J Barber; S L Stephenson; D F Gray
Journal:  N Engl J Med       Date:  1998-07-09       Impact factor: 91.245

8.  Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

Authors:  R Sobesky; P Mathurin; F Charlotte; J Moussalli; M Olivi; M Vidaud; V Ratziu; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

9.  Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition.

Authors:  André Van Gossum; Loris Pironi; Bernard Messing; Christophe Moreno; Antonio Colecchia; Antonietta D'Errico; Pieter Demetter; Françoise De Gos; Dominique Cazals-Halem; Francisca Joly
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-06-09       Impact factor: 4.016

10.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

View more
  4 in total

1.  Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.

Authors:  Mi Young Jeon; Hye Won Lee; Seung Up Kim; Ja Yoon Heo; Sojung Han; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han
Journal:  Hepatol Int       Date:  2017-02-21       Impact factor: 6.047

2.  Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.

Authors:  Shintaro Ichikawa; Utaroh Motosugi; Nobuyuki Enomoto; Hiroshi Onishi
Journal:  Eur Radiol       Date:  2018-07-24       Impact factor: 5.315

3.  The relationship between serum hepatitis B virus DNA level and liver histology in patients with chronic HBV infection.

Authors:  Changjiang Liu; Li Wang; Huizhong Xie; Liyuan Zhang; Bingshu Wang; Chun Luo; Suiqun Wang; Mingliang Tang; Zhongbiao Fu; Hailan Ruan; Zhengjin Liu; Ling Wei; Wenyi Yi; Yunqian Xie
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

4.  Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.

Authors:  Zhaoqin Wu; Haodong Tang; Lishan Wang; Xiaoling Jin; Zhengqing Lei; Pinghua Yang; Jiahua Zhou
Journal:  BMC Surg       Date:  2022-03-21       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.